1. Kim J, Choe YJ, Jang EJ, Lim DS, Kim YY, Kim RK, et al. Effectiveness of booster mRNA vaccines against SARS-CoV-2 infection in an elderly population, South Korea, October 2021-January 2022. Clin Infect Dis. 2022; 75(5):920–921. PMID:
35439294.
2. Thompson MG, Natarajan K, Irving SA, Rowley EA, Griggs EP, Gaglani M, et al. Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance - VISION Network, 10 States, August 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022; 71(4):139–145. PMID:
35085224.
3. Andrews N, Stowe J, Kirsebom F, Toffa S, Sachdeva R, Gower C, et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England. Nat Med. 2022; 28(4):831–837. PMID:
35045566.
4. Asian Development Bank. The Republic of Korea’s Coronavirus Disease Pandemic Response and Health System Preparedness. Metro Manila, Philippines: Asian Development Bank;2021. p. 66.
5. Korea Disease Control and Prevention Agency. COVID-19 vaccination. Accessed April 21, 2022.
https://ncv.kdca.go.kr/
.
6. Ministry of Health and Welfare. Coronavirus (COVID-19), Republic of Korea. Accessed April 21, 2022.
https://ncov.kdca.go.kr/
.
8. Cho HJ. Equity in health care: current situation in South Korea. J Korean Med Assoc. 2013; 56(3):184–194.
9. Pažitný P, Kandilaki D, Mužik R, Benková B. COVID-19 case fatality rate in the context of healthcare system organization and EHCI performance: focus on the Visegrad (V4) countries. Acta Oecon. 2021; 71(S1):35–52.
10. Lee SH, Park SY, Seon JY, Jeon WH, Nam SI, Park JH, et al. Intensive care unit capacity and its associated risk factors during the COVID-19 surge in the Republic of Korea: analysis using nationwide health claims data. Risk Manag Healthc Policy. 2020; 13:2571–2581. PMID:
33209067.
11. Kim JH, Hong SK, Kim Y, Ryu HG, Park CM, Lee YS, et al. Experience of augmenting critical care capacity in Daegu during COVID-19 incident in South Korea. Acute Crit Care. 2020; 35(2):110–114. PMID:
32506876.
12. Jo Y, Shrestha S, Radnaabaatar M, Park H, Jung J. Optimal social distancing policy for COVID-19 control in Korea: a model-based analysis. J Korean Med Sci. 2022; 37(23):e189. PMID:
35698839.
13. Park IN, Yum HK. Stepwise strategy of social distancing in Korea. J Korean Med Sci. 2020; 35(28):e264. PMID:
32686376.
15. McLaughlin JM, Khan F, Pugh S, Swerdlow DL, Jodar L. County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: an ecological analysis. Lancet Reg Health Am. 2022; 9:100191. PMID:
35128511.